Publications: Miss Christine Hughes

Nowinski S, Balarajah V, Baker A-M, Katainen R, Hughes C, Guo Q, Zapata L, Lakatos E et al. ( 2024 ) . Abstract B011: Lower incidence of small intestinal adenocarcinomas may be due to constrained copy number karyotype and increased immune surveillance . Cancer Research vol. 84 , ( 3_Supplement_2 ) b011 - b011 .

Zardab M, Balarajah V, Banerjee A, Stasinos K, Saad A, Imrali A, Hughes C, Roberts R et al. ( 2022 ) . Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study . Cancers vol. 15 , ( 1 )

Goulart MR, Watt J, Siddiqui I, Lawlor RT, Imrali A, Hughes C, Saad A, ChinAleong J et al. ( 2021 ) . Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma . npj Precision Oncology vol. 5 , ( 1 )

Kocher HM, Basu B, Froeling FE, Sarker D, Slater S, Carlin D, deSouza NM, De Paepe KN et al. ( 2020 ) . STARPAC clinical trial . Pancreatology vol. 20 , ( 8 )

Imrali A, Hughes CS, Coetzee AS, Delvecchio FR, Saad A, Roberts R, Chelala C, ChinAleong J et al. ( 2020 ) . Validation of a Novel, Flash‐Freezing Method: Aluminum Platform . Current Protocols Essential Laboratory Techniques vol. 21 , ( 1 )

Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, deSouza NM, De Paepe KN et al. ( 2020 ) . Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer . Nature Communications vol. 11 , ( 1 )

Hughes CS, ChinAleong J-A, Kocher HM ( 2020 ) . CRABP2 and FABP5 expression levels in diseased and normal pancreas . Annals of Diagnostic Pathology vol. 47 ,

Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, Coetzee C, de Souza N et al. ( 2019 ) . 700P STAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer . Annals of Oncology vol. 30 ,